Induction of differential patterns of local cerebral glucose metabolism and immediate-early genes by acute clozapine and haloperidol

Neuropharmacology

Volumn 43, Issue 3, 2002, Pages 394-407

  Cochran, S M ^a   McKerchar, C E ^a   Morris, B J ^a,b   Pratt, J A ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

2 Deoxyglucose autoradiography; Antipsychotics; Corticolimbothalamic circuit; In situ hybridisation; Papez circuit; Schizophrenia

Indexed keywords

CLOZAPINE; DEOXYGLUCOSE; HALOPERIDOL; PROTEIN FOS; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR FRA 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN CORTEX; CINGULATE GYRUS; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; EMOTION; GENE EXPRESSION; GENE INDUCTION; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; IMMEDIATE EARLY GENE; IN SITU HYBRIDIZATION; LEARNING; LIMBIC CORTEX; MALE; MAMMILLARY BODY; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PSYCHOSIS; RAT; SYMPTOMATOLOGY; THALAMUS;

ANIMALS; ANTIMETABOLITES; ANTIPSYCHOTIC AGENTS; AUTORADIOGRAPHY; BRAIN CHEMISTRY; CLOZAPINE; DEOXYGLUCOSE; DOPAMINE ANTAGONISTS; GENE EXPRESSION REGULATION; GENES, IMMEDIATE-EARLY; GLUCOSE; HALOPERIDOL; IN SITU HYBRIDIZATION; MALE; NERVE NET; OLIGONUCLEOTIDE PROBES; RATS; RATS, LONG-EVANS; RNA, MESSENGER;

EID: 0036711473     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(02)00091-6     Document Type: Article

References (68)

1. Andreasen N.C., Arndt S., Swayze V.N., Cizadlo T., Flaum M., O'Leary D., Ehrhardt J.C., Yuh W.T. Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science. 266:1994;294-298.
2. Boegman R.J., Vincent S.R. Involvement of adenosine and glutamate receptors in the induction of c-fos in the striatum by haloperidol. Synapse. 22:1996;70-77.
3. Brown K.W., White T. The association among negative symptoms, movement disorders, and frontal lobe psychological deficits in schizophrenic patients. Biological Psychiatry. 30:1991;1182-1190.
4. Carvey P.M., Braun A.R., Kao L.C., Klawans H.L. Effects of dopamine antagonists and apomorphine on regional energy metabolism in rat CNS. Clinical Neuropharmacology. 10:1987;247-260.
5. Chinenov Y., Kerppola T.K. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene. 20:2001;2438-2452.
6. Claghorn J., Honigfeld G., Abuzzahab F.S.S., Wang R., Steinbook R., Tuason V., Klerman G. The risks and benefits of clozapine versus chlorpromazine. Journal of Clinical Psychopharmacology. 7:1987;377-384.
7. Cochran S.M., McKerchar C., Morris B.J., Pratt J.A. Clozapine and haloperidol evoke differential patterns of local cerebral glucose utilisation in the rat. British Journal of Pharmacology. 126:1999;289P.
8. Cohen D.R., Curran T. fra-1: a serum-inducible, cellular immediate-early gene that encodes a fos-related antigen. Molecular and Cellular Biology. 8:1988;2063-2069.
9. Colangelo V., Di Grezia R., Passarelli F., Musicco M., Pontieri F.E., Orzi F. Differential effects of acute administration of clozapine or haloperidol on local cerebral glucose utilization in the rat. Brain Research. 768:1997;273-278.
10. Cook D., Wirtshafter D. Quinpirole attenuates the striatal immediate early gene expression, but not the hyperactivity, induced by the serotonin agonist RU-24969. Brain Research. 852:2000;247-254.
11. Crane A.M., Porrino L.J. Adaptation of the quantitative 2-[14C]deoxyglucose method for use in freely moving rats. Brain Research. 499:1989;87-92.
12. Crocker A.D., Hemsley K.M. An animal model of extrapyramidal side effects induced by antipsychotic drugs: relationship with D2 dopamine receptor occupancy. Progress in Neuro-Psycho-pharmacology: Biological Psychiatry. 25:2001;573-590.
13. Curran T., Gordon M.B., Rubino K.L., Sambucetti L.C. Isolation and characterization of the c-fos(rat) cDNA and analysis of post-translational modification in vitro. Oncogene. 2:(1):1987;79-84.
14. Deutch A.Y. The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia. Journal of Neural Transmission, Supplementum. 36:1992;61-89.
15. Deutch A.Y. Identification of the neural systems subserving the actions of clozapine: clues from immediate-early gene expression. Journal of Clinical PsychiatryB). 55:(Suppl B):1994;37-42.
16. Deutch A.Y., Duman R.S. The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization. Neuroscience. 70:1996;377-389.
17. Dilts R.P. Jr, Helton T.E., McGinty J.F. Selective induction of Fos and FRA immunoreactivity within the mesolimbic and mesostriatal dopamine terminal fields. Synapse. 13:1993;251-263.
18. Duncan G.E., Leipzig J.N., Mailman R.B., Lieberman J.A. Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation. Brain Research. 812:1998;65-75.
19. Fink-Jensen A., Kristensen P. Effects of typical and atypical neuroleptics on Fos protein expression in the rat forebrain. Neuroscience Letters. 182:1994;115-118.
20. Goldman-Rakic P.S. Architecture of the prefrontal cortex and the central executive. Annals of the New York Academy of Sciences. 769:1995;71-83.
21. Guillery R.W., Feig S.L., Lozsadi D.A. Paying attention to the thalamic reticular nucleus. Trends in Neurosciences. 21:1998;28-32.
22. Hiroi N., Graybiel A.M. Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum. Journal of Comparative Neurology. 374:1996;70-83.
23. Hughes P., Dragunow M. Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacological Reviews. 47:1995;133-178.
24. Jones E.G. Functional subdivision and synaptic organization of the mammalian thalamus. International Review of Physiology. 25:1981;173-245.
25. Kane J.M., Honigfeld G., Singer J., Meltzer H. Clozapine in treatment-resistant schizophrenics. Psychopharmacology Bulletin. 24:1988;62-67.
26. Kapur S., Zipursky R., Jones C., Remington G., Houle S. Relationship between dopamine D2 occupancy, clinical response, and side effects: A double-blind PET study of first-episode schizophrenia. American Journal of Psychiatry. 157:2000;514-520.
27. Kawaguchi Y., Kubota Y. GABAergic cell subtypes and their synaptic connections in rat frontal cortex. Cerebral Cortex. 7:1997;476-486.
28. Kuroda M., Yokofujita J., Murakami K. An ultrastructural study of the neural circuit between the prefrontal cortex and the mediodorsal nucleus of the thalamus. Progress in Neurobiology. 54:1998;417-458.
29. Lewis D.A. GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia. Brain Research Reviews. 31:2000;270-276.
30. Lewis D.A., Pierri J.N., Volk D.W., Melchitzky D.S., Woo T.U. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia. Biological Psychiatry. 46:1999;616-626.
31. Lidwell K., Griffiths R. Possible role for the FosB/JunD AP-1 transcription factor complex in glutamate-mediated excitotoxicity in cultured cerebellar granule cells. Journal of Neuroscience Research. 62:2000;427-439.
32. Litt L., Gonzalez-Mendez R., James T.L. An in vivo study of halothane uptake and elimination in the rat brain with fluorine nuclear magnetic resonance spectroscopy. Anaesthesiology. 67:1987;161-168.
33. MacGibbon G.A., Lawlor P.A., Bravo R., Dragunow M. Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja. Molecular Brain Research. 23:1994;21-32.
34. Manabe T., Ogita Y., Nakamichi N., Yoneda Y. Differential in vitro degradation of particular Fos family members expressed by kainic acid in nuclear and cytosolic fractions of murine hippocampus. Journal of Neuroscience Research. 64:2001;34-42.
35. Matsui M., Tokuhara M., Konuma Y., Nomura N., Ishizaki R. Isolation of human fos-related genes and their expression during monocyte-macrophage differentiation. Oncogene. 5:1990;249-255.
36. Matthysse S. Dopamine and the pharmacology of schizophrenia: the state of the evidence. Journal of Psychiatric Research. 11:1974;107-113.
37. McCulloch J., Savaki H.E., Sokoloff L. Distribution of effects of haloperidol on energy metabolism in the rat brain. Brain Research. 243:1982;81-90.
38. Meltzer H.Y., Stahl S.M. The dopamine hypothesis of schizophrenia: a review. Schizophrenia Bulletin. 2:1976;19-76.
39. Merchant K.M., Dorsa D.M. Differential induction of neurotensin and c-fos gene expression by typical vs. atypical antipsychotics. Proceedings of the National Academy of Sciences of the United States of America. 90:1993;3447-3451.
40. Merchant K.M., Figur L.M., Evans D.L. Induction of c-fos mRNA in rat medial prefrontal cortex by antipsychotic drugs: role of dopamine D2 and D3 receptors. Cerebral Cortex. 6:1996;561-570.
41. Miller J.C. Induction of c-fos mRNA expression in rat striatum by neuroleptic drugs. Journal of Neurochemistry. 54:1990;1453-1455.
42. Millbrandt J. A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science. 238:1987;797-799.
43. Miyata S., Tsujioka H., Itoh M., Matsunaga W., Kuramoto H., Kiyohara T. Time course of Fos and Fras expression in the hypothalamic supraoptic neurons during chronic osmotic stimulation. Molecular Brain Research. 90:2001;39-47.
44. Morgan J.I., Curran T. Stimulus-transcription coupling in neurons: role of cellular immediate-early genes. Trends in Neurosciences. 12:1989;459-462.
45. Morgan J.I., Cohen D.R., Hempstead J.L., Curran T. Mapping patterns of c-fos expression in the central nervous system after seizure. Science. 237:1987;192-197.
46. Morris B.J. Stimulation of immediate-early gene expression in striatal neurones by nitric oxide. Journal of Biological Chemistry. 270:1995;24740-24744.
47. Murphy C.A., Feldon J. Interactions between environmental stimulation and antipsychotic drug effects on forebrain c-fos activation. Neuroscience. 104:2001;717-730.
48. Palacios J.M., Wamsley J.K., Kuhar M.J. High affinity GABA receptors-autoradiographic localization. Brain Research. 222:1981;285-307.
49. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. Fourth Ed: 1998;Academic Press, Sydney.
50. Pizzolato G., Soncrant T.T., Rapoport S.I. Haloperidol and cerebral metabolism in the conscious rat: relation to pharmacokinetics. Journal of Neurochemistry. 43:1984;724-732.
51. Roberts L.A., Higgins M.J., O'Shaughnessy C.T., Stone T.W., Morris B.J. Changes in hippocampal gene expression associated with the induction of long-term potentiation. Molecular Brain Research. 42:1996;123-127.
52. Robertson G.S., Fibiger H.C. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience. 46:1992;315-328.
53. Robertson G.S., Fibiger H.C. Effects of olanzapine on regional C-Fos expression in rat forebrain. Neuropsychopharmacology. 14:1996;105-110.
54. Robertson G.S., Matsumura H., Fibiger H.C. Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. Journal of Pharmacology and Experimental Therapeutics. 271:1994;1058-1066.
55. Sagar S.M., Sharp F.R., Curran T. Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science. 240:1988;1328-1331.
56. Schotte A., Janssen P.F., Megens A.A., Leysen J.E. Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Brain Research. 631:1993;191-202.
57. Sebens J.B., Koch T., Ter Horst G.J., Korf J. Differential Fos-protein induction in rat forebrain regions after acute and long-term haloperidol and clozapine treatment. European Journal of Pharmacology. 273:1995;175-182.
58. Sebens J.B., Koch T., Ter Horst G.J., Korf J. Olanzapine-induced Fos expression in the rat forebrain; cross-tolerance with haloperidol and clozapine. European Journal of Pharmacology. 353:1998;13-21.
59. Sesack S.R., Deutch A.Y., Roth R.H., Bunney B.S. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. Journal of Comparative Neurology. 290:1989;213-242.
60. Sharp F.R., Sagar S.M., Swanson R.A. Metabolic mapping with cellular resolution: c-fos vs. 2-deoxyglucose. Critical Reviews in Neurobiology. 7:1993;205-228.
61. Sheng M., Greenberg M.E. The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron. 4:1990;477-485.
62. Simpson C.S., Morris B.J. Induction of c-fos and zif/268 gene expression in rat striatal neurones following stimulation of D1-like dopamine receptors involves protein kinase A and protein kinase C. Neuroscience. 68:1995;97-106.
63. Sokoloff L., Reivich M., Kennedy C., Des Rosiers M.H., Patlak C.S., Pettigrew K.D., Sakurada O., Shinohara M. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. Journal of Neurochemistry. 28:1977;897-916.
64. Tarazi F.I., Shirakawa O., Tamminga C.A. Low dose raclopride spares the extrapyramidal system in rat brain from metabolic effects. European Journal of Pharmacology. 232:1993;71-77.
65. Wan W., Ennulat D.J., Cohen B.M. Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain. Brain Research. 688:1995;95-104.
66. Weinberger D.R., Berman K.F., Zec R.F. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Archives of General Psychiatry. 43:1986;114-124.
67. Woo T.U., Whitehead R.E., Melchitzky D.S., Lewis D.A. A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 95:1998;5341-5346.
68. Zerial M., Toschi L., Ryseck R.P., Schuermann M., Muller R., Bravo R. The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity. EMBO Journal. 8:1989;805-813.